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1. Introduction 
The w-oxidation of fatty acids in mammals has 
been shown to be catalyzed by the cytochrome P-450- 
linked monooxygenase system in liver as well as 
kidney microsomes [ 1,2]. The products formed in 
both tissues include the w- and (w-1)-hydroxy fatty 
acids [ 2,3]. BjSrkhem and co-workers found differ- 
ences in the formation of the w-hydroxy and (o-l)- 
hydroxy products by liver microsomes [ 3-51, which 
were interpreted as due to the involvement of two 
different cytochrome P-450 species in these hydroxyl- 
ations [4,5]. It was subsequently speculated by 
Mold&s et al. [6] that of the two enzymes involved, 
the w-hydroxylase would be specific for fatty acid 
hydroxylation while the (w- l)-hydroxylase might be 
equivalent to the less specific cytochrome P-450 
catalyzing the hydroxylation of a great variety of 
foreign compounds including many drugs and other 
xenobiotics. This hypothesis was also in line with the 
findings of Frommer et al. [7] in their study on the 
hydroxylation of n-hexane by liver microsomes. 
In contrast, kidney microsomal fatty acid hydroxyl- 
ation was found by Ellin et al. [8] to most probably 
be due to the action of only one species of cytochrome 
P-450, cytochrome P-450, [2], catalyzing the forma- 
tion of both the w- and the (o-l)-hydroxy products 
at a ratio determined by the length of the fatty acid. 
This cytochrome F450K-linked monooxygenase 
system had earlier been shown to be specific towards 
fatty acid hydroxylation [2,9]. 
Recently, O’Brien and co-workers [lo] demon- 
strated that liver microsomal cytochrome P-450 
dependent hydroxylations of aromatic compounds 
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could be supported by cumene hydroperoxide which 
provided the hydroxylation reaction with both 
reducing equivalents and oxygen, thus replacing 
NADPH and molecular oxygen. In this paper we have 
studied the cumene hydroperoxide-supported fatty 
acid hydroxylation catalyzed by liver and kidney 
microsomes as well as partially purified cytochrome 
P-450 and cytochrome P-450,. Results are presented 
which strongly support the assumption that liver 
microsomes contain both an o- and an (w--l)- 
hydroxylase, the (w-l)-hydroxylase being the less 
substrate specific of the two also catalyzing the 
hydroxylation of other non-fatty acid compounds. 
The o-hydroxylase of liver microsomes is probably 
closely related to the specific fatty acid hydroxylase 
of kidney microsomes. 
2. Materials and methods 
Unstarved, male Sprague-Dawley rats (200 g) were 
used in this study. Liver and kidney microsomes were 
isolated as described elsewhere [8,1 l] and protein 
was determined according to Lowry et al. [ 121. 
Partially purified cytochrome P-450 from liver micro- 
somes and cytochrome P-450, from kidney micro- 
somes, were prepared as described by Lu and Levin 
[ 131 and by Mold&s et al. [6], respectively. 
NADPH- and O2 -dependent lauric acid hydroxyl- 
ation was measured after aerobic incubation of micro- 
somes with sodium laurate according to Ellin et al. 
[2]. When cumene hydroperoxide was used, the pH 
was set to 8.0 and Mg2+, Mn2+, NADF, isocitrate and 
isocitrate dehydrogenase were omitted from the 
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incubation mixture. The incubations were started by 
the addition of cumene hydroperoxide (5-30 mM 
suspension in water) using a microliter syringe. 
Although the reaction was linear with time for only 
5 min, the incubation time was set to 10 min in order 
to be able to detect also very low activities. The 
hydroxylated products were assayed using the gas 
liquid chromatographic method of Bjijrkhem and 
Danielsson [3], slightly modified by Ellin et al. [8]. 
Cytochrome P-450 was determined as described 
by Kupfer and Orrenius ([ 141, cf. [9]). 
Laurie acid, NADP* and isocitrate were obtained 
from Sigma Chemical Co. (St. Louis, MO., USA), iso- 
citrate dehydrogenase from Boehringer GMBH 
(Mannheim, Germany), i4C-labelled lauric acid from 
The Radiochemical Centre (Amersham, England) and 
cumene hydroperoxide from E. Merck (Darmstadt, 
Germany). All other chemicals were standard commer- 
cial products obtained from local sources. 
3. Results 
When liver microsomes were incubated with lauric 
acid in the presence of cumene hydroperoxide, 
(o- 1)hydroxy lauric acid was formed. On the other 
hand, no detectable amount of o-hydroxy lauric acid 
was observed. The pH optimum of the (w-l)-hydroxyl- 
ation reaction was about pH 8. As may be seen in 
fig. 1, the rate of (w- 1)hydroxylation increased with 
increasing cumene hydroperoxide concentration to 
about 7.5 PM after which concentration a sharp 
decrease in activity occurred. Using a standard incuba- 
tion mixture containing NADPH, the same liver 
microsomal preparation catalyzed the formation of 
both w- and (w- 1)hydroxy lauric acid at a ratio of 
1: 5 and the activity was only slightly higher than with 
cumene hydroperoxide. 
In contrast, kidney microsomes, which were highly 
active with NADPH as a source of reducing equivalents, 
produced only very small amounts of (o- 1)hydroxy 
lauric acid with cumene hydroperoxide, and no o- 
hydroxy lauric acid at all was detected. 
Cumene hydroperoxide-supported lauric acid 
hydroxylation was also assayed using samples of 
partially purified cytochrome P-450 and cytochrome 
P-450, instead of microsomes. The results are pre- 
sented in fig.2. As with liver microsomes, only (w-1). 
500 
[Cumene hydroperoxide], JJM 
Fig. 1. Cumene hydroperoxide-supported hydroxylation of 
lauric acid catalyzed by liver (0) and kidney (0) microsomes. 
With liver microsomes protein concentration was 0.44 mg/ml, 
with kidney microsomes 0.55 mg/ml. P-450 concentration 
was 0.35 nmol/ml and 0.10 nmol/ml respectively. NADPH- 
supported activities were in nmol/min mg protein with liver 
microsomes (w-l)-OH: 0.73; w-OH: 0.15 and with kidney 
microsomes (w-l)-OH: 0.82; w-OH: 1.13. 
hydroxy lauric acid could be detected after incuba- 
tion of liver cytochrome P-450 with lauric acid. The 
optimal cumene hydroperoxide concentration was 
four times higher than with liver microsomes, although 
5ocl 
[Cumene hydroperoxide], JJM 
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Fig.2. Cumene hydroperoxide-supported Iauric acid hydroxy- 
lation catalyzed by partially purified liver cytochrome P-450 
(0) and kidney cytochrome P-450 (0). Cytochrome P-450 
concentration was 2.3 nmol/ml and cytochrome P-450~ 
concentration was 0.10 nmol/ml. 
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the hydroxylation activity per cytochrome P-450 was 
lower than with microsomes. As expected, almost 
diminishingly small amounts of (o- l)-hydroxy lauric 
acid were produced by partially purified cytochrome 
P-450,. 
4. Discussion 
Since previous studies by Ziegler et al. [ 151 and 
O’Brien and collaborators [lo] had shown that cyto- 
chrome P-450 can catalyze an organic hydroperoxide 
dependent hydroxylation of various amines and 
aromatic compounds, presumably due to a peroxidase- 
like function of this hemoprotein, we undertook this 
series of experiments using lauric acid as a substrate 
with two goals in mind. Firstly, we wanted to inves- 
tigate whether cytochrome P-450 dependent fatty 
acid hydroxylation can also be supported by the 
organic hydroperoxide and, secondly, we were 
interested as to whether different cytochrome P-450 
species may reveal differences with regards to their 
interaction with the hydroperoxide. As outlined 
above, previous work by BjSrkhem and collaborators 
[3-51, as well as in our laboratory [6,8] had clearly 
indicated that different cytochrome P-450 species are 
involved in the w- and (w-l)-hydroxylation of fatty 
acids in liver microsomes, whereas a single cytochrome 
P-450 species (w-hydroxylase) seems to support the 
same reactions in kidney microsomes. The present 
study has given further strong support for this 
assumption. 
Thus, in the presence of cumene hydroperoxide 
liver microsomes and the partially purified liver micro- 
somal cytochrome P-450 preparation catalyzed 
exclusively the (o- l)-hydroxylation of lauric acid, 
whereas the corresponding kidney preparations 
produced minimal, but significant, amounts of the 
same product. In no case was the w-hydroxy derivative 
formed in the cumene hydroperoxide-supported 
system. It is also interesting to note that the (o--l)- 
hydroxylation activity in liver microsomes reached a 
sharp maximum at a hydroperoxide concentration of 
about 75 PM. This is similar to the previous finding 
with 3,4-benzpyrene as substrate [lo] and possibly 
due to a destruction of cytochrome P-450 at higher 
peroxide concentrations. 
Most interesting is the finding that no w-hydroxy 
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lauric acid was found in the cumene hydroperoxide- 
supported system suggesting that only the (o-l)- 
hydroxylase can interact with the organic hydro- 
peroxide. In contrast to the w-hydroxylase, the 
(w-1)-hydroxylase of liver microsomes has also 
previously been shown to share other properties with 
the ‘non-specific’ drug hydroxylase present in these 
particles, i.e. inducibility by phenobarbital treatment 
[3] and inhibition with SKF 525-A and metyrapone 
[6]. On the other hand, the w-hydroxylase of liver 
microsomes behaves similar to the fatty acid hydroxy- 
lase (w- and (w-l)) of kidney microsomes with 
respect to lack of response to the same inducer and 
inhibitors [2,6]. As evident in fig. 1, also kidney 
microsomes seem to contain a low proportion of the 
‘non-specific’ (w-1)hydroxylase which, however, 
would contribute less than 10% to the overall lauric 
acid hydroxylation activity in this fraction. This 
would also be in accordance with the finding that rat 
kidney microsomes show a low but significant 
hydroxylation activity with some non-fatty acid 
compounds [9]. 
In conclusion, this study has provided further 
evidence that i) two cytochrome P-450 species are 
involved in the w- and (o- l)-hydroxylation of fatty 
acids in liver microsomes, whereas a single cytochrome 
P-450 species (w-hydroxylase) catalyzes by far the 
major part of fatty acid hydroxylation in kidney 
microsomes, ii) that a similar, possibly identical, o- 
hydroxylase is present in both liver and kidney micro- 
somes and iii) that this enzyme can catalyze both the 
o- and (o- I)-hydroxylation of fatty acids at a ratio 
determined by the length of the fatty acid, whereas 
the (o-1)hydroxylase cannot catalyze hydroxylation 
in the w-position. 
Acknowledgements 
This study was supported by a grant from the 
Swedish Medical Research Council (proj. no 03X- 
247 1). 
References 
[l] Wada, F. (1968) Biochim. Biophys. Acta 162, 518. 
[2] Ellin, A., Jakobsson, S. V., Schenkman, J. B. and 
Orrenius, S. (1972) Arch. Biochem. Biophys. 150,64. 
Volume 5 0, number 3 FEBS LETTERS February 1975 
[ 31 Bjorkhem, I. and Danielsson, H. (1970) Eur. J. Blo- 
them. 17,450. 
[4] Hamberg, M. and Bjorkhem, I. (1971) J. Biol. Chem. 
246,741l. 
[ 5 ] Bjorkhem, I. and Hamberg, M. (1972) Biochem. Bio- 
phys. Res. Commun. 47, 333. 
[ 61 Mold&s, P., Ellin, A., Thor, H. and Orrenius, S. (1974) 
in: Regulation of Hepatic Metabolism (Lundqvist, F. 
and Tygstrup, N., eds.) p. 659, Munksgaard, Copen- 
hagen. 
[7] Frommer, U., Ullrich, V. and Orrenius, S. (1974) FEBS 
Lett. 41, 14. 
[S] Ellin, A., Orrenius, S., Pilotti, A. and Swahn, C.-G. 
(1973) Arch. Biochem. Biophys. 158, 597. 
[9] Orrenius, S., Ellin, A., Jakobsson, S. V., Thor. H., 
Cinti, D., Schenkman, J. B. and Estabrook, R. W. 
(1973)Drug Metab. Disp. 1, 350. 
[lo] Rahimtula, A. D. and O’Brien, P. J. (1974) Biochem. 
Biophys. Res. Commun. 60, 440. 
[ 111 Ernster, L., Siekevitz, P. and Palade, G. (1962) J. Cell. 
Biol. 15,541. 
[ 121 Lowry, 0. H., Rosebrough, N. J., Farr, A. L. and 
Randall, R. J. (1951) J. Biol. Chem. 193, 265. 
[ 131 Lu, A. Y. H. and Levin, W. (1972) Biochem. Biophys. 
Res. Commun. 46, 1334. 
[14] Kupfer, D. and Orrenius, S. (1970) Mol. Pharmacol. 6, 
221. 
[15] Kadlubar, F. F., Morton, K. C. and Ziegler, D. M. 
(1973) Biochem. Biophys. Res. Commun. 54, 1255. 
381 
